BioHib®

Haemophilus influenzae type b (Hib) Conjugate Vaccine

• Formulation: Lyophilized powder with purified PRP (polyribosyl-ribitol-phosphate) conjugated to tetanus toxoid
• Presentation: Single-dose vial with separate diluent
• Administration: Intramuscular injection
• Indications: Prevention of invasive diseases caused by Hib in infants and children
• Regulatory Status: Approved by Indian FDA (DCGI)
• Export Documentation: Certificate of Analysis (CoA), Package Insert, GMP Certificate, Cold Chain Declaration